Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00277732
Status:
COMPLETED
Last Update Posted:
2007-12-28
First Post:
2006-01-13
Brief Title:
Pharmaceutical Care for Diabetes Type 2 Patients a Randomised Controlled Trial
Sponsor:
University Ghent
Organization:
University Ghent
Study Overview
Official Title:
Pharmaceutical Care for Diabetes Type 2 Patients a Randomised Controlled Trial
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients Patients will be randomly allocated to the control group no input from pharmacist or intervention group with pharmaceutical care at baseline and follow-up visits over 6 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None